Health Care & Life Sciences » Biotechnology | Capstone Therapeutics Corp.

Capstone Therapeutics Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
173.00
160.00
157.00
179.00
205.00
254
Gross Income
173.00
160.00
157.00
179.00
205.00
1,746
SG&A Expense
4,120.00
4,364.00
2,782.00
1,405.00
1,475.00
1,927
EBIT
4,293.00
4,524.00
2,939.00
1,584.00
1,680.00
181
Non Operating Income/Expense
-
43.00
28.00
-
-
106
Interest Expense
-
-
-
81.00
111.00
145
Pretax Income
4,135.00
4,567.00
2,963.00
1,665.00
1,791.00
432
Income Tax
21.00
400.00
192.00
56.00
36.00
52
Consolidated Net Income
4,114.00
4,167.00
2,771.00
1,609.00
1,755.00
380
Net Income
3,921.00
4,167.00
2,771.00
663.00
1,755.00
380
Net Income After Extraordinaries
3,921.00
4,167.00
2,771.00
663.00
1,755.00
380
Net Income Available to Common
3,921.00
4,167.00
2,771.00
663.00
1,755.00
380
EPS (Basic)
0.10
0.10
0.07
0.02
0.04
0.01
Basic Shares Outstanding
40,885.00
40,885.00
40,885.00
40,885.00
47,173.00
54,385
EPS (Diluted)
0.10
0.10
0.07
0.02
0.04
0.01
Diluted Shares Outstanding
40,885.00
40,885.00
40,885.00
40,885.00
47,173.00
54,385
EBITDA
4,120.00
4,364.00
2,782.00
1,405.00
1,475.00
24
Non-Operating Interest Income
158.00
-
4.00
-
-
-
Minority Interest Expense
193.00
-
-
946.00
-
-

About Capstone Therapeutics

View Profile
Address
1275 West Washington Street
Tempe Arizona 85281
United States
Employees -
Website http://www.capstonethx.com
Updated 07/08/2019
Capstone Therapeutics Corp. is a biotechnology company. It develops a pipeline of novel therapeutic peptides and other molecules aimed at helping patients with under-served medical conditions. The company was founded in July 1987 and is headquartered in Tempe, AZ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.